Recon: Novavax gets first emergency authorization in Indonesia; J&J pays $800M to settle most Risperdal suits
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy